UOC
QTTB icon

UBS O'Connor’s Q32 Bio QTTB Stock Holding History

UBS O'Connor’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,229
Closed -$590K – 591
2024
Q3 		$590K Buy
13,229
+1,229
+10% +$45.2K 0.01% 333
2024
Q2 		$215K Buy
+12,000
New +$287K 0.01% 416

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

UBS O'Connor's QTTB Position: Q4 2024 in Review

UBS O'Connor sold out of Q32 Bio (QTTB) in Q4 2024, closing a stake of 13,229 shares — an estimated $590K sold.

UBS O'Connor first reported a position in QTTB in Q2 2024 and held it in 2 quarters. The position peaked at $590K in Q3 2024. 92 funds tracked by Wall St. Rank hold QTTB as of Q4 2024.

  • UBS O'Connor reported no remaining Q32 Bio position as of Q4 2024 after selling out during the quarter.
  • UBS O'Connor sold 13,229 Q32 Bio shares in Q4 2024, an estimated $590K.
  • UBS O'Connor first reported a position in Q32 Bio in Q2 2024 and held it in 2 quarters.
  • UBS O'Connor's Q32 Bio position peaked at $590K in Q3 2024.
  • 92 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2024.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.